|
Medical Ethics
Citations 1-10 of 83 total displayed.
|
Most recent content
(11 May 2009):
|
- Editorials
Time for the Medical Profession to Act: New Policies Needed Now on Interactions Between Pharmaceutical Companies and Physicians
- Philip Greenland
Arch Intern Med 2009; 169: 829-831.
[Extract]
[Full text]
[PDF]
|
Past content
(since Feb 1998):
|
- Editor's Correspondence
Men, Androgen Deficiency, and Pharmaceutical Promotion—Reply
- Susan A. Hall; Andre B. Araujo; Thomas G. Travison; Gretchen R. Esche; John B. McKinlay; Richard V. Clark; Rachel E. Williams
Arch Intern Med 2009; 169: 88-a-89-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Men, Androgen Deficiency, and Pharmaceutical Promotion
- Thomas E. Finucane
Arch Intern Med 2009; 169: 88.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Antibiotic Therapy in Elderly Persons Affected by Severe Dementia
- Renzo Rozzini; Marco Trabucchi
Arch Intern Med 2008; 168: 2497-b-2498-b.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Population Health for the Patient With Diabetes—Reply
- Paula M. Trief
Arch Intern Med 2008; 168: 2498-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Population Health for the Patient With Diabetes
- Bradley Flansbaum
Arch Intern Med 2008; 168: 2498.
[Extract]
[Full text]
[PDF]
- Editorials
The Natural History of Breast Cancer
- Robert M. Kaplan; Franz Porzsolt
Arch Intern Med 2008; 168: 2302-2303.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Participants in Phase 1 Oncology Research Trials Are Vulnerable
- Ron Berghmans
Arch Intern Med 2008; 168: 2287-2288.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Participants in Phase 1 Oncology Research Trials Are Vulnerable—Reply
- Christine Grady; Justine Seidenfeld; Elizabeth Horstmann; Ezekiel J. Emanuel
Arch Intern Med 2008; 168: 2288.
[Extract]
[Full text]
[PDF]
- Corrections
Error in Group Information in: Why Patients Continue to Participate in Clinical Research
-
Arch Intern Med 2008; 168: 1866.
[Full text]
[PDF]
|
|
